» Articles » PMID: 21873412

Functional Selectivity at the μ-opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance

Overview
Journal Pharmacol Rev
Specialty Pharmacology
Date 2011 Aug 30
PMID 21873412
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

Opioids are the most effective analgesic drugs for the management of moderate or severe pain, yet their clinical use is often limited because of the onset of adverse side effects. Drugs in this class produce most of their physiological effects through activation of the μ opioid receptor; however, an increasing number of studies demonstrate that different opioids, while presumably acting at this single receptor, can activate distinct downstream responses, a phenomenon termed functional selectivity. Functional selectivity of receptor-mediated events can manifest as a function of the drug used, the cellular or neuronal environment examined, or the signaling or behavioral measure recorded. This review summarizes both in vitro and in vivo work demonstrating functional selectivity at the μ opioid receptor in terms of G protein coupling, receptor phosphorylation, interactions with β-arrestins, receptor desensitization, internalization and signaling, and details on how these differences may relate to the progression of analgesic tolerance after their extended use.

Citing Articles

Biased Opioid Receptor Agonists: Balancing Analgesic Efficacy and Side-Effect Profiles.

Ju J, Li Z, Liu J, Peng X, Gao F Int J Mol Sci. 2025; 26(5).

PMID: 40076488 PMC: 11899445. DOI: 10.3390/ijms26051862.


Development and preclinical testing of a naloxone prodrug depot for extended protection against opioid overdose.

Aldawod H, Patel A, Emara R, Liang D, Ho J, Amin T Nat Commun. 2025; 16(1):686.

PMID: 39848946 PMC: 11758388. DOI: 10.1038/s41467-025-55945-4.


Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors.

Gomes I, Gupta A, Margolis E, Fricker L, Devi L Mol Pharmacol. 2024; 106(5):240-252.

PMID: 39187388 PMC: 11493337. DOI: 10.1124/molpharm.124.000947.


G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.

Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S Signal Transduct Target Ther. 2024; 9(1):88.

PMID: 38594257 PMC: 11004190. DOI: 10.1038/s41392-024-01803-6.


Effect of pretreatment with a small dose of esketamine on sufentanil-induced cough during anesthesia induction: a randomized controlled trial.

Gao L, Zhang Z, Zhu Y, Lu X, Tian Y, Wei L BMC Anesthesiol. 2024; 24(1):116.

PMID: 38528479 PMC: 10964693. DOI: 10.1186/s12871-024-02501-0.


References
1.
Luttrell L, Ferguson S, Daaka Y, Miller W, Maudsley S, Della Rocca G . Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999; 283(5402):655-61. DOI: 10.1126/science.283.5402.655. View

2.
Keith D, Murray S, Zaki P, CHU P, Lissin D, Kang L . Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem. 1996; 271(32):19021-4. DOI: 10.1074/jbc.271.32.19021. View

3.
Pak Y, ODowd B, George S . Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J Biol Chem. 1997; 272(40):24961-5. DOI: 10.1074/jbc.272.40.24961. View

4.
Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H . Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001; 19(9):2542-54. DOI: 10.1200/JCO.2001.19.9.2542. View

5.
Pan Y, Xu J, Bolan E, Abbadie C, Chang A, Zuckerman A . Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol Pharmacol. 1999; 56(2):396-403. DOI: 10.1124/mol.56.2.396. View